All In Biotech

Free tool

FAERS Monitor: Potassium Chloride 30meq In Dextrose 5% and Sodium Chloride 0.9% In Plastic Container

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 019308 or its brand name (Potassium Chloride 30meq In Dextrose 5% and Sodium Chloride 0.9% In Plastic Container, Dextrose, Potassium Chloride, Sodium Chloride). Reports on generic versions are filed under their own applications.

Reports

11

Serious

4

36% of reports

Hospitalization

3

Death reported

0

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • blood potassium increased2
  • physical product label issue2
  • product label confusion2
  • product label issue2
  • product packaging confusion2
  • atrial fibrillation1
  • atrial flutter1
  • bradycardia1
  • cardiac arrest1
  • flushing1
  • incorrect product storage1
  • infusion related reaction1
  • product barcode issue1
  • product name confusion1
  • product quality issue1

Reports by year received

View as table
YearReports
20141
20152
20161
20172
20213
20222

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,148 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
product barcode issue14971.5765.11,239
physical product label issue23222.2918.73,616
product name confusion11756.0270.7438
product packaging confusion21576.6449.81,769
product label confusion2656.4187.3735
product label issue2563.9160.9631
atrial flutter1239.637.059
blood potassium increased2235.767.3262
incorrect product storage1145.522.535
bradycardia136.15.68
infusion related reaction128.84.56
cardiac arrest123.23.65
atrial fibrillation119.63.04
flushing118.82.94
product quality issue114.12.23

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.